Journal
INTERNATIONAL IMMUNOLOGY
Volume 21, Issue 1, Pages 53-62Publisher
OXFORD UNIV PRESS
DOI: 10.1093/intimm/dxn123
Keywords
-
Categories
Funding
- Spanish Ministry of Education and Science [SAF03/05184, SAF06/03687]
- Spanish Ministry of Health [FIS PI061320]
- Junta de Extremadura, Spain [03/2, 3PR05A012]
- European Regional Development Fund (FEDER)
- Outcome and Impact of Specific Treatment in European Research on Melanoma [QLRT-2001-00668]
- 5th Framework Program of the European Union [QLK6-CT2002-02283]
- 6th FP European Network [503306]
- AIDS Research and Reference Reagent Program
- NIAID
- NIH
- Maurice Gately, Hoffmann-La Roche Inc
Ask authors/readers for more resources
Adoptive transfer of antigen-specific CD8(+) T cells may represent an effective strategy for immunotherapy of tumors such as melanoma, but is limited by the number and functionality of in vitro expanded T cells. Here, we document that although ELAGIGILTV-specific CD8(+) T cells from different donors initially possessed a naive phenotype, after antigen-induced in vitro expansion two distinct phenotypes correlating with cell proliferation rate emerged in the different donors. Those cultures achieving fewer cumulative population doublings (CPDs) were cytotoxic and displayed a CD45RA(+)CCR7(-) phenotype. In contrast, cultures reaching higher CPDs were non-cytotoxic T cells with a CD45RA(-)CCR7(-) phenotype. Thus, the generation of larger numbers of ELAGIGILTV-specific CD8(+) T cells correlates negatively with the acquisition of a CD45RA(+)CCR7(-) phenotype and cytotoxic capacity. A better understanding of the differentiation pathways of cytotoxic T cells to obtain optimally efficient cells for adoptive transfer will allow the development of new immunotherapy protocols.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available